On this page you can find more information about the speakers mentioned in the programme. We are also very grateful that prof. dr. Beatriz Noheda is our chairman of the day!
Dr. Kim Bonger: Kim Bonger obtained a PhD in organic chemistry at Leiden University in 2008 after which she went for a postdoc at Stanford University in the USA. In 2013, she started her independent research group in the field of chemical biology as part of the department of biomolecular chemistry at the Radboud University in Nijmegen, the Netherlands. Her research focusses on the development of novel molecules and (bio)technologies to investigate the cells mechanisms on the control, degradation or sequestering of misfolded proteins. Furthermore, her research focusses on strategies to treat diseases that arise from misfolded proteins and protein aggregates.
Prof. dr. Klaas Poelstra: Klaas Poelstra is a Co-Founder of BiOrion Technologies BV and serves as its Chief Scientific officer. Prof. Dr. Poelstra serves as the Chairman of the Drug Targeting group in the Department of Pharmacokinetics and Drug Delivery at the University of Groningen and has been its Adjunct-Professor since 2004. Prof. Dr. Poelstra has a strong scientific background focussing on the design of novel anti-inflammatory proteins and on drug targeting strategies. He is an inventor of many compounds under development in several Biotech start-ups, such as alkaline phosphatase and protein-based drug carriers. He was honoured for the "NWO Vernieuwingsimpuls 2000" and the Galenus Research Award 2003. In 2006, he was awarded with the most prestigious NWO grant "VICI grant" in the Netherlands. Prof. Dr. Poelstra received his PhD in Medical Biology in 1992 (cum laude).
Prof. dr. Wesley Browne: Wesley Browne studied at the Dublin City University in Ireland from 1995 to 1999, after which he began his doctoral studies in Chemistry at the same university. Browne performed a Research Fellowship (2003-2007) in the group of Prof. Dr B. L. Feringa, at the University of Groningen. After being an Assistant Professor at the Stratingh Institute for Chemistry, he became an Associate Professor for Functional Molecular Materials and Catalytic Systems at this institute. From 2015, Wesley Browne is the Chair of the Molecular Inorganic Chemistry group of the University of Groningen. During his career, Browne got several awards, including the Chancellor’s Award for Outstanding Achievement (Dublin City University, 1999) and the Prize for Young Chemists (National Committee for Chemistry, The Royal Irish Academy, 2002).
Dr. Bill Morandi: Bill Morandi was born in Fribourg, Switzerland in 1983. He studied at the ETH Zurich from 2003 to 2008, earning a BSc in Biology and a MSc in Chemical Biology. After performing his master thesis on the decarbonylation of aldehydes, he performed his doctoral studies in organic synthesis.
In 2012, he moved to the California Institute of Technology to work under the guidance of Prof. Grubbs. As a SNSF postdoctoral fellow at Caltech, he initiated a new research program aiming to develop efficient and general catalytic oxidation reactions of internal alkenes. In 2014, Dr. Morandi was awarded an independent Max Planck Research Group Leader Position by the Max Planck Society. He founded and leads the "Homogeneous Catalysis and Reaction Design" group at the Max-Planck-Institut für Kohlenforschung in Mülheim/Ruhr.
Pim Mul obtained a PhD in organometallic chemistry at the University of Amsterdam after which he joined Shell in 1990. During his career at Shell he held various research and management positions, and was a member of the organizing committee of various scientific conferences (KNCV Catalysis Symposium, NCCC III-VI). Part of his work at Shell has been made public through patents, publications in open literature, and presentations at conferences and universities. He has been responsible for the development of various in-house technology programs including ‘Filling-the-Funnel’ for Shell Chemicals and the research program for the WaterTechnology platform.
Currently, he leads the "Molecular Innovation" team in the Emerging Technologies department. This team supports several existing businesses, including Shell Chemicals, Refining, Integrated Gas and Gas-to-Liquids, and it plays a key role in developing Shell's Future Energies’ agenda. In this field, Shell prepares itself for the energy transition and associated challenges and opportunities. The scope of this work includes alternative energy carriers, PV, and techno-economic assessments. The team conducts both in-house R&D and drives open innovation through collaborations with academia, industrial partners, and other innovation centers.
Prof. dr. Paolo Melchiorre: Paolo Melchiorre is an ICREA Research Professor at the Institute of Chemical Research of Catalonia (ICIQ) in Tarragona. Paolo, born in 1973 in Camerino, Italy, studied Chemistry at the University of Bologna where he graduated in 1999. Then he began his doctoral studies in Chemistry working in the area of enantioselective catalysis. Before obtaining his PhD in 2003, he spent a research period in Denmark working with Prof. Karl Anker Jørgensen at the "Center for Catalysis", Århus University, where his studies centered on asymmetric organocatalysis. Afterwards, he worked as a postdoctoral associate at the Industrial Chemistry Faculty of the Bologna University. There, he began his studies on the development of novel organocatalytic asymmetric transformations. In October 2007, he took a permanent position as an Assistant Professor at Bologna University. In September 2009, Paolo moved to Catalonia as ICREA Research Professor and ICIQ Group Leader.